S. Korean firm acquires Pharmexa unit

Submitted by YONHAP on

SEOUL, Oct. 31 (Yonhap) -- Kael Co., a South Korean biotechnology start-up, said Friday it has acquired Gemvax, a unit of Danish cancer-vaccine maker Pharmexa A/S.

(Copyright)

Submitted by YONHAP on

All information carried by the Yonhap News Agency, including articles,

X